Search

everythinglearnresearchcommunity

for

Search:↓

TTD hair brittleness is caused by multiple structural abnormalities.

The DNS FUE technique offers discreet hair transplants with high satisfaction and low damage rates.

Emotional stress can trigger intermittent hair loss in chronic telogen effluvium, which may not improve with treatment if stress continues.

Technology, like stem cell therapy and teledermatology, is improving dermatology care.

The EDAR gene mutation leads to thinner and more deformed hair shafts.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Tea tree oil is more effective for treating human demodicosis than other treatments.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Topical tacrolimus can effectively treat erosive pustular dermatosis and related hair loss.

Severe digestive issues in DRESS need early endoscopy for better treatment.

Most genetic mutations causing hypohidrotic ectodermal dysplasia in Russian patients are found in the EDA gene.

The enzymes Tet2 and Tet3 are important for skin cell development and hair growth.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Scientists now better understand the genetics of hypohidrotic ectodermal dysplasia, leading to more accurate diagnoses and potential new treatments.

Hair loss in Telogen effluvium is often chronic, linked to stress, and lacks a confirmed treatment, but topical corticosteroids may be used.

Teledermatology can effectively treat certain skin conditions with topical treatments, reducing the need for in-person visits.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Equisetum debile extract, especially the ethyl acetate type, may be a promising natural ingredient for anti-hair loss products.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

Calcipotriene ointment improved a child's skin condition known as En coup de sabre.

A patient experienced intense hair loss due to telogen effluvium after scalp contact dermatitis, but hair regrew completely within two months without further treatment.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Terminalia chebula fruit extract helps hair growth by reducing DHT and boosting hair cell activity.

A new method can quickly and accurately detect drugs in hair.

Epristeride's metabolism in zebrafish helps improve doping detection methods.